Fludarabine-melphalan reduced-intensity conditioning matched sibling bone marrow stem cell transplantation is an effective treatment for myeloid disorders

被引：0
|
作者：
Malladi, R
Peniket, A
Collins, G
Littlewood, T
机构：
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
[2] John Radcliffe Hosp Clin Haematol, Oxford, England
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [1] Favorable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning allogeneic bone marrow stem cell transplantation.
    Malladi, RK
    Peniket, AJ
    Norton, AE
    Samol, J
    Campbell, AJ
    Jones, J
    Keen-McGuire, A
    Littlewood, TJ
    BLOOD, 2003, 102 (11) : 469B - 469B
  • [2] Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies
    Malladi, RK
    Peniket, AJ
    Norton, AE
    Campbell, AJ
    Collins, GP
    Samol, J
    Eagleton, H
    Miller, E
    Morgenstern, G
    Jones, J
    Keen-Mcguire, A
    Barnardo, M
    Littlewood, TJ
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (02) : 85 - 92
  • [3] Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas
    Delioukina, M.
    Zain, J.
    Palmer, J. M.
    Tsai, N.
    Thomas, S.
    Forman, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 (01) : 65 - 72
  • [4] Reduced-Intensity Conditioning Is Successful in Matched Sibling Bone Marrow Transplantation As a Cure for Sickle Cell Disease
    Agarwal, Shreya
    Patel, Krupesh
    Gillio, Alfred
    Hankewycz, Melanie
    Durning, Nancy
    Haugh, Jeanette
    Adler-Brecher, Barbara
    Krajewski, Jennifer
    BLOOD, 2017, 130
  • [5] Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
    Kekre, Natasha
    Marquez-Malaver, Francisco J.
    Cabrero, Monica
    Pinana, Jl
    Esquirol, Albert
    Soiffer, Robert J.
    Caballero, Dolores
    Terol, M. J.
    Martino, Rodrigo
    Antin, Joseph H.
    Lopez-Corral, L.
    Solano, Carlos
    Armand, Philippe
    Perez-Simon, Jose A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1808 - 1815
  • [6] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Takuya Yamashita
    Akiyoshi Takami
    Naoyuki Uchida
    Takahiro Fukuda
    Tetsuya Eto
    Souichi Shiratori
    Shuichi Ota
    Takashi Akasaka
    Shigesaburo Miyakoshi
    Tadakazu Kondo
    Michihiro Hidaka
    Junya Kanda
    Yoshiko Atsuta
    Shingo Yano
    Bone Marrow Transplantation, 2020, 55 : 1955 - 1965
  • [7] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Yamashita, Takuya
    Takami, Akiyoshi
    Uchida, Naoyuki
    Fukuda, Takahiro
    Eto, Tetsuya
    Shiratori, Souichi
    Ota, Shuichi
    Akasaka, Takashi
    Miyakoshi, Shigesaburo
    Kondo, Tadakazu
    Hidaka, Michihiro
    Kanda, Junya
    Atsuta, Yoshiko
    Yano, Shingo
    BONE MARROW TRANSPLANTATION, 2020, 55 (10) : 1955 - 1965
  • [8] Melphalan Dose in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation with Reduced-Intensity Fludarabine and Melphalan
    Harada, Kaito
    Machida, Shinichiro
    Yanada, Masamitsu
    Kanamori, Heiwa
    Onizuka, Makoto
    Ozawa, Yukiyasu
    Kobayashi, Hikaru
    Sawa, Masashi
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yano, Shingo
    BLOOD, 2017, 130
  • [9] Fludarabine-melphalan as reduced-intensity conditioning for allogeneic stem cell transplantation in AML beyond complete remission: 10-year single centre experience
    Karas, M.
    Steinerova, K.
    Svoboda, T.
    Lysak, D.
    Vokurka, S.
    Vozobulova, V.
    Jindra, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S400 - S401
  • [10] Reduced-intensity stem cell transplantation with fludarabine and melphalan for children with haematological malignancies
    Kato, K.
    Maeda, N.
    Kigasawa, H.
    Tsuchida, M.
    Kurosawa, H.
    Taga, T.
    Sano, H.
    Adachi, S.
    Horibe, K.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S292 - S292
12345